Niki BioSolutions, Inc. (NIKI) Receivables - Net (2018 - 2025)

Niki BioSolutions' (NIKI) quarterly Receivables - Net came in at $131091.0 in Q4 2025, up 30.29% on a QoQ basis from $100613.0 in Q3 2025.

Niki BioSolutions, Inc. (NIKI) Receivables - Net (2018 - 2025) Analysis & Trends

Niki BioSolutions (NIKI) has 8 years of Receivables - Net data on file, last reported at $131091.0 in Q4 2025.

Quarterly Receivables - Net changed N/A year-over-year to $131091.0 in Q4 2025, while the trailing twelve-month figure through Nov 2025 was $131091.0 (changed N/A YoY) and the FY2024 annual result came in at $89281.0, changed N/A from the prior year.
Receivables - Net rose to $131091.0 in Q4 2025, from $100613.0 in the prior quarter.
In the past five years, Receivables - Net ranged from a high of $174426.0 in Q4 2022 to a low of $47093.0 in Q2 2021.
A 5-year average of $89682.8 and a median of $78722.0 in 2021 frame the typical range for Receivables - Net.
Annual changes were most pronounced in 2022 — Receivables - Net soared 121.57% — and 2023, when it tumbled 72.65%.
Tracing NIKI's Receivables - Net over 5 years: stood at $78722.0 in 2021, then soared by 121.57% to $174426.0 in 2022, then plunged by 72.65% to $47709.0 in 2023, then soared by 87.14% to $89281.0 in 2024, then soared by 46.83% to $131091.0 in 2025.
The last three Receivables - Net figures came in at $131091.0 (Q4 2025), $100613.0 (Q3 2025), and $89281.0 (Q2 2024), per Business Quant data.

Download Data